within Pharmacolibrary.Drugs.R_RespiratorySystem.R06A_AntihistaminesForSystemicUse.R06AA61_DimenhydrinateCombinations;

model DimenhydrinateCombinations
  extends Pharmacolibrary.Drugs.ATC.R.R06AA61;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R06AA61</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dimenhydrinate is an antihistamine used primarily to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is a combination of diphenhydramine and 8-chlorotheophylline. The drug is available over-the-counter in many countries and remains widely used for motion sickness and vertigo.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, as published data specifically for dimenhydrinate, combinations (R06AA61) are not available; estimates are based on the main active moiety diphenhydramine.</p><h4>References</h4><ol><li><p>Ehling, S, et al., &amp; Papich, MG (2019). Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: a pilot study. <i>Veterinary dermatology</i> 30(2) 91–e24. DOI:<a href=\"https://doi.org/10.1111/vde.12727\">10.1111/vde.12727</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30779257/\">https://pubmed.ncbi.nlm.nih.gov/30779257</a></p></li><li><p>Nachum, Z, et al., &amp; Gordon, CR (2006). Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. <i>Clinical pharmacokinetics</i> 45(6) 543–566. DOI:<a href=\"https://doi.org/10.2165/00003088-200645060-00001\">10.2165/00003088-200645060-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16719539/\">https://pubmed.ncbi.nlm.nih.gov/16719539</a></p></li><li><p>Culy, CR, et al., &amp; Plosker, GL (2001). Ondansetron: a review of its use as an antiemetic in children. <i>Paediatric drugs</i> 3(6) 441–479. DOI:<a href=\"https://doi.org/10.2165/00128072-200103060-00007\">10.2165/00128072-200103060-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11437189/\">https://pubmed.ncbi.nlm.nih.gov/11437189</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end DimenhydrinateCombinations;
